Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Cannage Capital is a venture capital firm based in the United States, dedicated to supporting early-stage visionary founders. The firm invests across the artificial intelligence stack, including semiconductors, software infrastructure, and applications. They focus on a diverse range of sectors, including biotech, healthcare, fintech, and consumer technology.
Cannage Capital invests in early-stage companies at the pre-seed, seed, seed+, and Series A stages. Their investment strategy targets technologies across the AI stack, emphasizing the intersection of various disciplines to drive breakthrough ideas. Check sizes are not specified, but the firm is open to a wide range of innovative sectors.
Cannage Capital has backed notable companies such as Cruise Automation, known for autonomous vehicle technology; Covariant, specializing in AI for robotics; and Human, focusing on privacy solutions. Other investments include Forter for fraud prevention, JupiterOne in cybersecurity, Sardine in fintech, Ginkgo Bioworks in biotechnology, and Hinge Health for digital health solutions.
Submit your pitch through their form at cannagecap.com.
Cannage Capital often leads investment rounds, particularly in early-stage companies where they see significant potential for growth.
The firm is open to follow-on investments, especially for companies that demonstrate strong performance and alignment with their investment thesis.
Specific details about the fund size are not publicly available, but Cannage Capital focuses on early-stage investments across multiple sectors.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.